Erik Supratik Mittra MD PhD
Professor of Diagnostic Radiology; Chief, Nuclear Medicine & Molecular Imaging; Oregon Health & Science University
Join to View Full Profile
3181 SW Sam Jackson Park RdPortland, OR 97239
Phone+1 503-418-0990
Fax+1 503-494-4982
Dr. Mittra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Erik Mittra is a Professor of Radiology at Oregon Health & Science University. He completed his medical education at Stony Brook University, followed by a residency and fellowship at Stanford University. He specializes in Nuclear Medicine with a clinical and research focus on Theranostics.
Education & Training
Stanford Health CareFellowship, PET/CT Clinical Oncology, 2008 - 2009
Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 2006 - 2008
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 2005 - 2006
Stony Brook University Health Sciences Center School of MedicineClass of 2005
Certifications & Licensure
WA State Medical License 2025 - 2026
OR State Medical License 2017 - 2025
CA State Medical License 2007 - 2018
American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- 4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy Start of enrollment: 2009 Dec 01
- A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours Start of enrollment: 2012 Sep 06
- 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas Start of enrollment: 2014 Dec 01
Publications & Presentations
PubMed
- 4 citationsSymptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.Kimberly Perez, Jaydira Del Rivero, Erin B Kennedy, Sandip Basu, Aman Chauhan
JCO Oncology Practice. 2026-01-01 - 1 citationsThe Current Practice of Theranostics: Results of a National Survey and Lessons Learned.Victoria West, Phillip Morse, Mike Nguyen, Razan Ali, Nadine Mallak
Journal of Nuclear Medicine Technology. 2025-12-04 - Phase 1 Study of [Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.Erik S Mittra, Lilja B Solnes, Astrid A M van der Veldt, Jeffrey Wong, Luigi Aloj
Journal of Nuclear Medicine. 2025-12-04
Authored Content
- It May Be Time to Stop Classifying Theranostics as a Radiology SubspecialtyJuly 2019
- It May Be Time to Stop Classifying Theranostics as a Radiology SubspecialtyJuly 2019
- Navigating the Evolving Landscape of Neuroendocrine TumorsJanuary 2019
Press Mentions
Clinical Challenges: Nuclear Medicine and Neuroendocrine TumorsApril 30th, 2020- Clinical Challenges: Nuclear Medicine and Biochemically Recurrent Prostate CancerApril 23rd, 2020
PET/MRI Evaluation of Cardiac AmyloidApril 13th, 2017
Grant Support
- [18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumorsOREGON HEALTH & SCIENCE UNIVERSITY2021–2026
Committees
- Member, OHSU MD/PhD Committee 2018 - Present
- Chair, SNMMI Committee on Chapters 2018 - Present
- Board Member, SNMMI Outreach Committee 2016 - Present
- Board Member, SNMMI Therapy Center of Excellence 2016 - Present
- Chair, SNMMI Targeted Radiotherapy Working Group 2016 - Present
Professional Memberships
- Society of Nuclear Medicine & Molecular ImagingMember
- International Society of Clinical DensitometryMember
Other Languages
- Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
